EMIT - ENSAIO DE METOTREXATO

Methotrexate · class III · Until 06/10/2033

Registration no.
10345161293
Process no.
25351202794200929
Status
Until 06/10/2033
Device type
Methotrexate (METOTREXATE)
Risk class
III
Registration holder
SIEMENS HEALTHCARE DIAGNÓSTICOS LTDA CNPJ 01.449.930/0001-90 · 2,590 registrations
Manufacturer
SIEMENS HEALTHCARE DIAGNOSTICS INC · United States
Published
10/08/2009
Valid until
06/10/2033
Last updated by ANVISA
2026-10-12
Official record
View on ANVISA ↗

Other methotrexate registrations (8 in total, see all)

ProductClass HolderPublishedStatus
Metotrexato (MTX) - SNIBE
10303460618
III IN VITRO DIAGNOSTICA LTDA 24/08/2026 Until 24/08/2036
Família Methotrexate
10287411705
III ROCHE DIAGNÓSTICA BRASIL LTDA 21/10/2024 Until 21/10/2034
Família Alinity i Methotrexate
80146502269
III ABBOTT LABORATORIOS DO BRASIL LTDA 03/08/2020 Until 03/08/2030
ARCHITECT Methotrexate Extended Range Controls
80146501930
III ABBOTT LABORATORIOS DO BRASIL LTDA 01/06/2015 Until 01/06/2035
ARCHITECT Methotrexate Controls
80146501928
III ABBOTT LABORATORIOS DO BRASIL LTDA 11/05/2015 Until 11/05/2035
ARCHITECT Methotrexate Calibrators
80146501929
III ABBOTT LABORATORIOS DO BRASIL LTDA 11/05/2015 Until 11/05/2035
ARCHITECT Methotrexate Reagent Kit
80146501923
III ABBOTT LABORATORIOS DO BRASIL LTDA 16/03/2015 Until 16/03/2035